📰 Celcuity Inc News
Page 7 - Celcuity Inc News Today
Fast, Ad-Free News Updates
Stay updated with breaking news from Celcuity Inc. Real-time updates on events, politics, business and more.
April 12, 2023
MINNEAPOLIS, MN / ACCESSWIRE / April 12, 2023 / Celcuity Inc. (NASDAQ:CELC), a clinical-stage biotechnology company focused on development of targeted therapies for oncology, today announced its participation
March 27, 2023
Operator: Greetings. And welcome to Celcuitys Full Year 2022 Financial Results Conference Call. At this time, all participants are in a listen-only mode.
March 23, 2023
Celcuity Inc. Reports Fourth Quarter and Full Year 2022 Financial Results ...
March 23, 2023
Dosing of first patient in VIKTORIA-1 in the fourth quarter triggered closing of $100 million PIPE financing and drawdown of $20 million term loan tranche, which extends cash runway through 2025Updated
March 16, 2023
MINNEAPOLIS, MN / ACCESSWIRE / March 15, 2023 / Celcuity Inc. (NASDAQ:CELC), a clinical-stage biotechnology company focused on development of targeted therapies for oncology, today announced publication
March 16, 2023
MINNEAPOLIS, MN / ACCESSWIRE / March 16, 2023 / Celcuity Inc. (NASDAQ:CELC), a clinical-stage biotechnology company focused on development of targeted therapies for oncology, today announced that it will
March 13, 2023
While Minnesota-based banks stocks slid this morning after the federal government stepped in to quell fear, experts say consumers should rest easy about their money.
December 20, 2022
/PRNewswire/ -- Purcell & Lefkowitz LLP, a class action law firm dedicated to representing shareholders nationwide, is investigating a potential breach of...
December 20, 2022
/PRNewswire/ -- Purcell & Lefkowitz LLP, a class action law firm dedicated to representing shareholders nationwide, is investigating a potential breach of...
December 9, 2022
High response rates and encouraging median progression free survival rates were observed in patients regardless of PIK3CA mutation statusMedian progression free survival (PFS) of 42.3 months was reported